Inhibition of C5a receptor alleviates experimental CNS lupus

A Jacob, B Hack, T Bai, JR Brorson, RJ Quigg… - Journal of …, 2010 - Elsevier
To investigate the role of C5a generated on complement activation in brain, the lupus model,
MRL/lpr mice were treated with C5a receptor (R) antagonist (ant). Neutrophil infiltration …

C3aR inhibition reduces neurodegeneration in experimental lupus

A Jacob, L Bao, J Brorson, RJ Quigg, JJ Alexander - Lupus, 2010 - journals.sagepub.com
Complement activation is an important aspect of systemic lupus erythematosus. In this study
we investigated the role of C3a/C3a receptor (R) signaling in brains of the lupus model …

Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease

I Farkas, M Takahashi, A Fukuda… - The Journal of …, 2003 - journals.aai.org
In our earlier results, we demonstrated that cells expressing the complement C5aR are
vulnerable since abnormal activation of C5aR caused apoptosis of these cells. In this study …

C5a/CD88 signaling alters blood–brain barrier integrity in lupus through nuclear factor‐κB

A Jacob, B Hack, P Chen, RJ Quigg… - Journal of …, 2011 - Wiley Online Library
J. Neurochem.(2011) 119, 1041–1051. Abstract Inflammation is a key factor in a number of
neurodegenerative diseases including systemic lupus erythematosus. The complement …

[HTML][HTML] C5a alters blood-brain barrier integrity in experimental lupus

A Jacob, B Hack, E Chiang, JGN Garcia… - The FASEB …, 2010 - ncbi.nlm.nih.gov
The blood-brain barrier (BBB) is a crucial anatomic location in the brain. Its dysfunction
complicates many neurodegenerative diseases, from acute conditions, such as sepsis, to …

[PDF][PDF] C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and …

Y Liu, SQ Xu, WJ Long, XY Zhang… - European Review for …, 2018 - europeanreview.org
OBJECTIVE: To discuss the effect of complement C52 (C5a) and complement C5a receptor
(C5aR) antagonists on inflammatory status of mouse microglial cells. MATERIALS AND …

Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune …

L Boos, IL Campbell, R Ames, RA Wetsel… - The journal of …, 2004 - journals.aai.org
The C3aR is expressed throughout the CNS and is increased in expression on glial cells
during CNS inflammation. However, the role that C3a and the C3aR play in chronic …

Soluble complement complex C5b-9 promotes microglia activation

C Yang, L Yang, Y Liu - Journal of neuroimmunology, 2014 - Elsevier
Soluble C5b-9 has been described as a pro-inflammatory mediator that triggers cell
activation rather than inducing cell death. Microglia is the most important immune cell …

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

MI Fonseca, SO McGuire, SE Counts… - Journal of …, 2013 - Springer
Background Alzheimer's disease (AD) is a neurodegenerative dementia characterized by
the decline of cognition and the presence of neuropathological changes including neuronal …

Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - The Journal of …, 2009 - journals.aai.org
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …